Effects of β𝟐 Agonists, Corticosteroids, and Novel Therapies on Rhinovirus-Induced Cytokine Release and Rhinovirus Replication in Primary Airway Fibroblasts

Table 1

Demographics of donors from whom fibroblasts used in this study were isolated.

Patient	Disease	Sex	Age (years)
1	Transposition of the great arteries	M	39
2	Chronic obstructive pulmonary disease (COPD)	M	56
3	No disease	M	48
4	Idiopathic pulmonary fibrosis (IPF)	M	61
5	Emphysema	M	63
6	Small cell carcinoma	M	63
7	Lymphangioleiomyomatosis (LAM)	F	51
8	Pulmonary fibrosis	M	53
9	Bronchiectasis	M	53
10	Emphysema	M	40
11	Non-small cell carcinoma	M	77
12	Cystic Fibrosis	M	45
13	Non Small Cell Carcinoma	F	63
14	Non-small cell carcinoma	F	79
15	Primary pulmonary hypertension	F	36
16	Lymphangioleiomyomatosis (LAM)	F	33
17	Emphysema	F	56
18	Emphysema	F	48
19	Melanoma	M	63
20	Carcinoma	M	59
21	Lesion	F	58
22	Resection	M	48
23	Carcinoma	F	83
24	Idiopathic pulmonary fibrosis (IPF)	M	57
25	Carcinoma	F	76
26	Emphysema	F	50
27	Idiopathic pulmonary fibrosis (IPF)	M	56
28	Pulmonary fibrosis	M	68
29	Rejection:pneumonitis	M	21
30	α1 antitrypsin deficiency	M	55
31	Hypersensitive pneumonitis	M	59
32	α1 antitrypsin deficiency	M	42
33	Emphysema	M	42
34	Bronchiectasis	M	39
35	Small cell Carcinoma	F	78